Viewing Study NCT03406858


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-02 @ 12:52 AM
Study NCT ID: NCT03406858
Status: COMPLETED
Last Update Posted: 2023-05-03
First Post: 2017-12-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration Levels of Testosterone View
None Castration-Resistant Prostate Carcinoma View
None Prostate Carcinoma Metastatic in the Bone View
None PSA Progression View
None Stage IV Prostate Adenocarcinoma AJCC v7 View
Keywords: